James Patrick Allison

1985-1997 Molecular and Cell Biology University of California, Berkeley, Berkeley, CA, United States 
 1997-2004 Rheumatology University of California, San Francisco, San Francisco, CA 
 2004-2012 Weill Cornell Medical College, New York, NY, United States 
 2006-2012 Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States 
 2012- Immunology M. D. Anderson Cancer Center, Houston, TX, United States 
"James Patrick Allison"

The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"

Mean distance: (not calculated yet)
Cross-listing: ImmunoTree


Sign in to add mentor
G Barrie Kitto grad student 1973 UT Austin
 (I. Isolation and characterization of a tumor inhibitory asparaginase from Alcaligenes eutrophus. II. Insolubilization of L-Asparaginase by covalent attachment to nylon tubing.)
Ralph Alfred Reisfeld post-doc 1974-1977 Scripps Institute
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Axelrod ML, Meijers WC, Screever EM, et al. (2022) T cells specific for α-myosin drive immunotherapy-related myocarditis. Nature
Hailemichael Y, Johnson DH, Abdel-Wahab N, et al. (2022) Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 40: 509-523.e6
Abbas HA, Hao D, Tomczak K, et al. (2021) Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nature Communications. 12: 6071
Sharma N, Atolagbe OT, Ge Z, et al. (2021) LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. The Journal of Experimental Medicine. 218
Goswami S, Chen Y, Anandhan S, et al. (2020) mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Science Translational Medicine. 12
Mitra A, Andrews MC, Roh W, et al. (2020) Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma. Nature Communications. 11: 1839
Subudhi SK, Vence L, Zhao H, et al. (2020) Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer. Science Translational Medicine. 12
Reuben A, Zhang J, Chiou SH, et al. (2020) Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nature Communications. 11: 603
Helmink BA, Reddy SM, Gao J, et al. (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature
Sharma P, Allison JP. (2020) Dissecting the mechanisms of immune checkpoint therapy. Nature Reviews. Immunology
See more...